3',4'-Dimethoxy-2,2,2-trifluoroacetophenone, 97.0%, 10g

1-(5-Bromopyrimidin-2-yl)-3-piperidinol, 95.0%, 5g

Colonna capillare per GC ROTI®Cap-5 MS, 15 m, 0.25 mm, 0.25 µm, 1 Pezzo(i)

1-Methyl-2-(methylthio)-1H-imidazole, 97.0%, 10g

(2E)-3-[4-(benzyloxy)phenyl]-1-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

6-Bromo-[1,2,4]triazolo[4,3-a]pyrazine, 98%, 500mg

4-n-Propylbenzaldehyde, 97.0%, 25g

2,4-Dichloro-1,8-naphthyridine, 95.0%, 10g

Tert-butyln-[(1r)-1-(5-bromo-4-methyl-2-pyridyl)ethyl]carbamate, 98%, 100mg

Dihydro-beta-ionone>90.0%(GC)25g

2-(Trifluoromethyl)piperazine, 97.0%, 100mg

(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate, 97.0%, 5g

(H-Cys-OH)2, 98.00%, 500g